This High-Yield Stock Is Positioning Itself to Grab Another Slice of a $321 Billion Opportunity
The high-paying stock is expanding a partnership so that it's in a better spot to capture more growth.
3 Stocks for Warren Buffett Fans
If you want to be like Buffett, here's a healthcare stock, an auto company, and an airline for you.
Can This Tiny Biotech Revolutionize a $35 Billion Market?
This upstart is developing a diagnostic test and treatment for nonalcoholic steatohepatitis, or NASH, an increasingly common liver disease.
The robotic vacuum specialist has been on quite a tear this year, but the ongoing trade dispute threw cold water on its progress.
The answer is not always age 62 -- and sometimes it's much, much younger.
And guess what? They're right.
Be greedy when others are fearful, but mind the potential pitfalls.
Marijuana legalization is creating a green rush among investors, but there are risks to consider.
When it comes to marijuana stocks, there are plenty of options for investors to choose from, but only some can be smart buys now.
It's not just the potential to legally sell dried flower that could move the needle for investors.
Amazon reinvents shopping yet again.
Google executives have been getting spanked on Capitol Hill again after a big data breach. Does it even matter?
Can these key catalysts keep up their momentum?
Which of these high-yield dividend stocks is the best investment today?
It sounds like a lot of money, but it may not go as far as you think.
AMC Stubs A-List is growing at the expense of disruptions and model tweaks at MoviePass.
Should you buy the Chinese search giant or the fast-growing Latin American marketplace?
OPEC's latest oil market report sees things differently.
Is bigger better in a battle between these two Canadian marijuana stocks?
The amount of earned income that will be taxable for Social Security is increasing in 2019.
Developers have long used this model to monetize their apps.
NVIDIA's R&D spending has grown significantly over the years.
Amazon's size alone may not lead to antitrust scrutiny. But some of its business strategies could land the company in hot water sooner or later.